Literature DB >> 28595539

Targeted Drug Delivery Systems and Their Therapeutic Applications in Cancer and Immune Pathological Conditions.

Jamshed Iqbal1, Fareeha Anwar2, Saifullah Afridi1.   

Abstract

BACKGROUND: More than a century ago, Paul Ehrlich proposed the idea of a drug working as a "magic bullet" that selectively eliminates diseased cells without harming the surrounding normal cells. Since then, much progress has been made in this field to broaden the scope for targeted delivery of drugs. A major problem remain the toxic effects of targeted drugs on healthy cells. In order to reduce the adverse effects of chemotherapy on healthy tissues, we survey the use of recent drug delivery systems for targeted therapy.
OBJECTIVE: The selective delivery of the drugs to specific diseased cells or tissues still is a daunting task. Ideally, for target drug delivery systems, the system should be made up of carriers and drugs, where carriers precisely target the desired drug. This issue covers the recent advancements in modern techniques for such purposes. RESULT AND
CONCLUSION: It encompasses advances, benefits and limitations in state of art work of targeted drug delivery through hydrogels, microfluidics, nanoparticles, carbon nanotubes, polymeric micelles, liposomes, lipoprotein based drug carriers and dendrites. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Cancer therapy; drug carriers; hydrogels; nanoparticles; polyoxometalate; targeted drug delivery.

Mesh:

Substances:

Year:  2017        PMID: 28595539     DOI: 10.2174/1871526517666170606102623

Source DB:  PubMed          Journal:  Infect Disord Drug Targets        ISSN: 1871-5265


  12 in total

Review 1.  Targeting the fungal cell wall: current therapies and implications for development of alternative antifungal agents.

Authors:  Sahar Hasim; Jeffrey J Coleman
Journal:  Future Med Chem       Date:  2019-04-17       Impact factor: 3.808

Review 2.  Kinetics of Nanomedicine in Tumor Spheroid as an In Vitro Model System for Efficient Tumor-Targeted Drug Delivery With Insights From Mathematical Models.

Authors:  Sayoni Maitra Roy; Vrinda Garg; Sourav Barman; Chitrita Ghosh; Amit Ranjan Maity; Surya K Ghosh
Journal:  Front Bioeng Biotechnol       Date:  2021-12-01

3.  G250 Antigen-Targeting Drug-Loaded Nanobubbles Combined with Ultrasound Targeted Nanobubble Destruction: A Potential Novel Treatment for Renal Cell Carcinoma.

Authors:  Zhiping Yu; Yixuan Wang; Dan Xu; Lianhua Zhu; Ming Hu; Qiuli Liu; Weihua Lan; Jun Jiang; Luofu Wang
Journal:  Int J Nanomedicine       Date:  2020-01-08

4.  Expression of serum response factor in the lung mesenchyme is essential for development of pulmonary fibrosis.

Authors:  Ksenija Bernau; Jonathan Paul Leet; Ellen Marie Bruhn; Austin James Tubbs; Terry Zhu; Nathan Sandbo
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-05-12       Impact factor: 6.011

Review 5.  The functions and applications of A7R in anti-angiogenic therapy, imaging and drug delivery systems.

Authors:  Lu Lu; Hongyuan Chen; Dake Hao; Xinke Zhang; Fengshan Wang
Journal:  Asian J Pharm Sci       Date:  2019-05-25       Impact factor: 6.598

Review 6.  Nanobody: a promising toolkit for molecular imaging and disease therapy.

Authors:  Guangfa Bao; Ming Tang; Jun Zhao; Xiaohua Zhu
Journal:  EJNMMI Res       Date:  2021-01-19       Impact factor: 3.138

7.  Comparative Evaluation of Engineered Polypeptide Scaffolds in HER2-Targeting Magnetic Nanocarrier Delivery.

Authors:  Victoria O Shipunova; Olga A Kolesnikova; Polina A Kotelnikova; Vladislav D Soloviev; Anton A Popov; Galina M Proshkina; Maxim P Nikitin; Sergey M Deyev
Journal:  ACS Omega       Date:  2021-06-10

Review 8.  Role of Calixarene in Chemotherapy Delivery Strategies.

Authors:  Rossella Basilotta; Deborah Mannino; Alessia Filippone; Giovanna Casili; Angela Prestifilippo; Lorenzo Colarossi; Gabriele Raciti; Emanuela Esposito; Michela Campolo
Journal:  Molecules       Date:  2021-06-29       Impact factor: 4.411

9.  Patient-Derived, Drug-Resistant Colon Cancer Cells Evade Chemotherapeutic Drug Effects via the Induction of Epithelial-Mesenchymal Transition-Mediated Angiogenesis.

Authors:  Jin Hong Lim; Kyung Hwa Choi; Soo Young Kim; Cheong Soo Park; Seok-Mo Kim; Ki Cheong Park
Journal:  Int J Mol Sci       Date:  2020-10-10       Impact factor: 5.923

10.  Cellular SPION Uptake and Toxicity in Various Head and Neck Cancer Cell Lines.

Authors:  Matthias Balk; Theresa Haus; Julia Band; Harald Unterweger; Eveline Schreiber; Ralf P Friedrich; Christoph Alexiou; Antoniu-Oreste Gostian
Journal:  Nanomaterials (Basel)       Date:  2021-03-13       Impact factor: 5.076

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.